NewsRx

Search our medical news database

Lung Disease

Inhaled Steroids Improve the Health of Patients

Published in Health and Medicine Week, May 22nd, 2000

A new study supports the widespread practice of using high dose inhaled corticosteroids in patients with moderate to severe chronic obstructive pulmonary disease (COPD).

COPD, which affects lung function, occurs predominantly in tobacco smokers and is a leading cause of illness and death worldwide. As lung function deteriorates (measured by forced expiratory volume - FEV) substantial changes in general health occur.

Dr. Peter Burge and colleagues report in the British Medical Journal on the ISOLDE trial in which 18 U.K. hospitals took part involving 751 patients who were current or former smokers. The men and women were aged between 40 and...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Health and Medicine Week


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook